WAT Waters Corporation
Trend channel, buy level and 3-month target. Information only, not financial advice.
Inside the channel · 9-month channel rising
Price is between the lines.
- 9-month channel
- US$447.83 – US$472.95 · rising, +83% a year
- Price in channel
- 59% (0% = floor, 100% = ceiling)
- Ceiling overhead
- US$472.95
- Turns bearish below
- US$447.83
- Published levels
- Buy and target are not from this channel — see below.
Price history, with the path projected 3 months forward
Updated 10:44 AM ET (49 h ago)
- Daily close
- Upper trend line (9 months)
- Lower trend line (9 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Suggested path
Buy at or below
US$418.84
level as at 9 Nov 2026
Our target
US$481.66
by 24 Nov 2026
Projected move
15.0%
gross, before costs
Price is between our buy and target.
Target: WAT's usual move size (15.0%), the best return per day on this path.
This move size: reached in 20% of 10 past stretches, typically in 26 days. (0.58% per day)
- Upper line touches
- 4
- Lower line touches
- 3
- Fit confidence
- 68%
- Fitted
- 1 Nov 2026
Company information
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra
- Employees
- 7,900
- Country
- US
Scorecard
Our own scores from the fundamentals below (not Morningstar ratings).
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$43.52B
- Enterprise value
- —
- Beta
- 1.19
- Avg volume
- 849.08K
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 282.77-445.48
- Exchange
- NYSE
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.